Metformin Hydrochloride
Zenofor contains metformin, a medicine used to treat diabetes. It belongs to a group of medicines called biguanides.
Insulin is a hormone produced by the pancreas that allows the body to use glucose (sugar) from the blood. The body uses glucose to produce energy or stores it for future use.
In diabetic patients, the pancreas does not produce enough insulin or the body is unable to use the produced insulin properly. This leads to an excessive increase in blood glucose levels. Zenofor helps to reduce blood glucose levels to as close to normal as possible.
In adults with overweight, long-term use of Zenofor also reduces the risk of complications associated with diabetes. Taking Zenofor is associated with maintaining body weight or moderate weight loss.
Zenofor is used to treat patients with type 2 diabetes (also known as non-insulin-dependent diabetes), in whom diet and physical exercise alone do not achieve adequate blood glucose control. It is particularly used in patients with overweight.
Adults can take Zenofor as the only medicine or in combination with other anti-diabetic medicines (oral or insulin).
Children from 10 years of age and adolescents can take Zenofor as the only medicine or in combination with insulin.
(see section 6).
If any of the above situations apply to you, you should consult your doctor before taking this medicine.
It is essential to consult your doctor if it is necessary:
Zenofor must be discontinued for a certain period before and after the examination or surgery. Your doctor will decide whether other treatment is necessary during this time. It is crucial to follow your doctor's instructions.
Zenofor may cause a very rare but very serious side effect called lactic acidosis, especially if you have kidney function disorders. The risk of lactic acidosis increases in case of uncontrolled diabetes, severe infection, prolonged fasting, or alcohol consumption, dehydration (see more information below), liver function disorders, and any conditions in which a part of the body is not adequately supplied with oxygen (e.g., severe heart disease).
If any of the above conditions apply to you, you should consult your doctor for more detailed instructions.
(significant water loss from the body), such as severe vomiting, diarrhea, fever, exposure to high temperatures, or if you drink less fluid than usual. You should consult your doctor for more detailed instructions.
as it can lead to coma.
Symptoms of lactic acidosis include:
Lactic acidosis is a life-threatening condition that requires immediate hospital treatment.
If you are to undergo major surgery, you must not take Zenofor during and for a certain period after surgery. Your doctor will decide when you should stop and resume taking Zenofor.
Zenofor does not cause hypoglycemia (low blood sugar). However, if Zenofor is taken with other anti-diabetic medicines that can cause hypoglycemia (such as sulfonylureas, insulin, meglitinides), there is a risk of hypoglycemia. If you experience symptoms of hypoglycemia, such as weakness, dizziness, increased sweating, rapid heartbeat, vision disturbances, or difficulty concentrating, eating or drinking a sugary drink usually helps.
During treatment with Zenofor, your doctor will check your kidney function at least once a year or more often if you are elderly and/or have impaired kidney function.
If you are to be injected with a contrast agent containing iodine into the bloodstream, for example, for an X-ray examination or computed tomography, you must discontinue taking Zenofor before or at the latest at the time of injection. Your doctor will decide when you should stop and resume taking Zenofor.
Tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take. You may need more frequent blood glucose checks and kidney function assessments or dose adjustments of Zenofor by your doctor.
It is particularly important to inform your doctor if you are taking:
Avoid consuming excessive amounts of alcohol while taking Zenofor, as it may increase the risk of lactic acidosis (see "Warnings and precautions").
If you are pregnant, think you may be pregnant, or plan to have a baby, you should consult your doctor, as changes in treatment or blood glucose monitoring may be necessary.
This medicine is not recommended for breastfeeding women or those planning to breastfeed.
Zenofor does not cause hypoglycemia (low blood sugar). This means it does not affect your ability to drive or use machines.
However, be cautious if you are taking Zenofor with other anti-diabetic medicines that can cause hypoglycemia (such as sulfonylureas, insulin, meglitinides). Symptoms of hypoglycemia include weakness, dizziness, increased sweating, rapid heartbeat, vision disturbances, or difficulty concentrating. If you experience such symptoms, do not drive or use machines.
Zenofor contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose, which means it is essentially "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Zenofor does not replace the benefits of a healthy lifestyle.
Continue to follow your doctor's recommendations regarding diet and regular physical activity.
Children from 10 years of age and adolescents: usually start with a dose of 500 mg or 850 mg of Zenofor once a day. The maximum daily dose is 2000 mg and is taken in 2 or 3 divided doses. Treatment of children from 10 to 12 years of age is only used if specifically recommended by a doctor, as experience with Zenofor in this age group is limited.
Adults: usually start with a dose of 500 mg or 850 mg of Zenofor, 2 or 3 times a day. The maximum daily dose is 3000 mg and is taken in 3 divided doses.
If you have impaired kidney function, your doctor may prescribe a lower dose.
If you are also taking insulin, your doctor will inform you how to start taking Zenofor.
Zenofor should be taken with a meal or immediately after a meal. This will help avoid gastrointestinal side effects.
Do not crush or chew the tablets. Swallow the tablet with a glass of water.
in the evening (dinner).
If you feel that the effect of Zenofor is too strong or too weak, you should consult your doctor or pharmacist.
If you take a higher dose of Zenofor than recommended, you may experience lactic acidosis. Symptoms of lactic acidosis are non-specific and include vomiting, abdominal pain (abdominal cramps), general malaise with severe fatigue, and breathing difficulties. Other symptoms include decreased body temperature and slowed heart rate. If you experience any of these symptoms, you should immediately seek medical attention, as lactic acidosis can lead to coma. You should immediately stop taking Zenofor and contact your doctor or the nearest hospital.
Do not take a double dose to make up for a missed dose. Take the next dose at the usual time. If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Zenofor can cause side effects, although not everybody gets them.
The following side effects may occur:
Limited data in children and adolescents indicate that the side effects are similar in nature and severity to those observed in adults.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. If a child is being treated with Zenofor, parents and caregivers are advised to supervise the use of this medicine.
There are no special storage precautions.
Do not use this medicine after the expiry date stated on the carton after "EXP".
The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance of Zenofor is metformin hydrochloride.
Each film-coated tablet of Zenofor 500 mg contains 500 mg of metformin hydrochloride, which corresponds to 390 mg of metformin.
Each film-coated tablet of Zenofor 850 mg contains 850 mg of metformin hydrochloride, which corresponds to 662.9 mg of metformin.
Each film-coated tablet of Zenofor 1000 mg contains 1000 mg of metformin hydrochloride, which corresponds to 780 mg of metformin.
The other ingredients of the medicine are:
Core: hypromellose 615, sodium carbonate anhydrous, povidone K 25, magnesium stearate
Coating: hypromellose 606, macrogol 6000, titanium dioxide (E 171)
Zenofor 500 mg, film-coated tablets:
White, round, biconvex film-coated tablets. One side of the tablet has a score line in the shape of a V. The diameter of the tablet is approximately 12 mm. The score line on the tablet is only to facilitate breaking the tablet to make it easier to swallow and not to divide it into equal doses.
Zenofor 850 mg, film-coated tablets:
White, oval, film-coated tablets. Both sides have a score line in the shape of a V. The dimensions of the tablet are approximately 19 x 8.7 mm. The score line on the tablet is only to facilitate breaking the tablet to make it easier to swallow and not to divide it into equal doses.
Zenofor 1000 mg, film-coated tablets:
White, oval film-coated tablets. Score lines are engraved on both sides of the tablet, in the shape of a V on one side. The dimensions of the tablet are approximately 19 x 10 mm. The tablet can be divided into equal doses.
PVC/Aluminum blisters in a cardboard box
Pack sizes:
Zenofor 500 mg: 20, 28, 30, 50, 56, 60, 84, 90, 100, 120, 180, 300, 400, 500 film-coated tablets
Zenofor 850 mg: 30, 40, 50, 56, 60, 80, 90, 100, 120, 180, 200, 500 film-coated tablets
Zenofor 1000 mg: 28, 30, 50, 56, 60, 80, 90, 100, 120, 180 film-coated tablets
Not all pack sizes may be marketed.
Zentiva, k.s.
U kabelovny 130
Dolní Měcholupy
102 37 Prague 10
Czech Republic
(marketing authorization holder logo)
S.C. ZENTIVA S.A.
B-dul Theodor Pallady nr.50, sector 3
032266 Bucharest
Romania
Mulado
Metformin Zentiva
Metformine Zentiva
Metformin Zentiva
Poland, Romania:
Zenofor
Lithuania:
Metformin hydrochloride Zentiva
Slovakia:
Mirovian
Zentiva Polska Sp. z o.o.
ul. Bonifraterska 17
00-203 Warsaw
tel.: +48 22 375 92 00
Czech Republic:
Denmark, Estonia,
Germany, Latvia,
Norway:
France:
Finland, Sweden:
Date of last revision of the leaflet:March 2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.